Bioavailability of Oral Hydrocortisone Corrected for Binding Proteins and Measured by LC-MS/MS Using Serum Cortisol and Salivary Cortisone
Anti-diabetics are medicines developed to stabilize and control blood glucose levels amongst people with diabetes. Therapeutic drug monitoring necessitates the measurement of their plasma concentration for studying the pharmacokinetics of these drugs, assessment of bioequivalence of commercially available tablet formulation and for optimization of dosing in combination therapy.
Combinations of two or more oral agents with different mechanisms of action are often used for the management of hyperglycaemia in type 2 diabetes. These combinations have customarily been taken as separate tablets, several fixed-dose single tablet combinations. These are based on bioequivalence with the separate tablets, giving similar efficacy to the separate tablets and necessitating the same cautions and contraindications that apply to each active component.
Related Journals of Bioequivalence Antidiabetics
Journal of Pharmaceutical Science and Research, International Journal of BioAnalytical Methods & BioEquivalence Studies, Journal of Bioequivalence & Bioavailability, MOJ Bioequivalence & Bioavailability, World Research Journal of Pharmaceutical Research, Bioanalytical Methods & Bioequivalence Studies, Enliven: Biosimilars and Bioavailablity, Chemical Speciation & Bioavailability, Pharmaceutical Regulatory Affairs: Open Access, Journal of Bioanalysis & Biomedicine.